Previous 10 | Next 10 |
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), today announced that Bill Lundberg, M.D....
2024-05-28 21:15:01 ET Citigroup analyst issues BUY recommendation for MRUS on May 28, 2024 08:02PM ET. The previous analyst recommendation was Buy. MRUS was trading at $54.87 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
2024-05-28 16:12:04 ET More on Merus Merus Stock: Priced High After An ASCO Surprise Surge (Maintain Buy) Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement Merus rallies on publication of oncology study abstracts Merus gets FDA breakthr...
2024-05-28 14:00:08 ET Etzer Darout from BMO Capital issued a price target of $84.00 for MRUS on 2024-05-28 11:51:00. The adjusted price target was set to $84.00. At the time of the announcement, MRUS was trading at $53.86. The overall price target consensus is at $61.75...
2024-05-28 12:00:11 ET Bradley Canino from Stifel Nicolaus issued a price target of $90.00 for MRUS on 2024-05-28 10:25:00. The adjusted price target was set to $90.00. At the time of the announcement, MRUS was trading at $54.8. The overall price target consensus is at $...
67% response rate observed among 24 evaluable patients Conference Call on Tuesday, May 28 th at 8 a.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage onco...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 428.5% to $0.983 on volume of 924,758,481 shares Greenwave Technology Solutions Inc. (GWAV) fell 4.2% to $0.0849 on volume of 393,457,542 shares Netcapital Inc. (NCPL) rose 10.1% to $0.1925 on volum...
2024-05-24 13:00:44 ET Summary Merus N.V. is experiencing significant growth and entering a higher price territory, making the risk-reward less clear. The company's bispecific antibody, petosemtamab, showed promising results in a phase 2 study for head and neck squamous cell carci...
2024-05-24 12:58:09 ET More on BioAtla, HOOKIPA Pharma, etc. BioAtla, Inc. (BCAB) Q1 2024 Earnings Call Transcript AEye, Inc. (LIDR) Q1 2024 Earnings Call Transcript BioAtla: A Buried ADC Concern Gets Some New Life In 2024 AEye Q1 2024 Earnings Preview ...
News, Short Squeeze, Breakout and More Instantly...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), today a...
2024-06-27 10:45:04 ET Aurora Innovation Inc (AUR) AUR is trading UP for the last 5 days, and it at trading at $2.79 with volume of 1,962,658 and a one day change of $0.15 (5.67%). Aurora Innovation Inc has a 52-week low of 1.30 and a 52-week high of $4.81. The business's 50-day mov...
2024-06-17 09:00:05 ET Bradley Canino from Stifel Nicolaus issued a price target of $99.00 for MRUS on 2024-06-17 07:26:00. The adjusted price target was set to $99.00. At the time of the announcement, MRUS was trading at $56.55. The overall price target consensus is at ...